Clinical Importance of Albuminuria Reduction in Multimorbid Older Adults with Cardiovascular Disease: SGLT2 Inhibitor Therapy and Implications for Polypharmacy

More on Chronic kidney disease

• The American Journal of Cardiology·8 Oct 2026

  Drug class linked to fewer deaths or complications in kidney disease

  

• Clinical Journal of the American Society of Nephrology·4 Oct 2026

  Lower physical performance links to heart failure and death in CKD

• Geriatrics & Gerontology International·4 Oct 2026

  Kidney dysfunction links to higher cognitive impairment risk

• Clinical Pharmacology and Therapeutics·4 Oct 2026

  SGLT2 inhibitors raise genital but not urinary infection risk